Preclinical CRO
Definition: A Preclinical Contract Research Organization (CRO) is a specialized company that provides outsourced laboratory and animal testing services to pharmaceutical, biotechnology, and academic researchers during the early phases of drug development.
Role in Drug Development: The preclinical phase occurs before a drug candidate is tested in human subjects (clinical trials). The CRO's primary role is to generate data necessary to evaluate the potential safety and biological effectiveness of a new compound, which is required by regulatory agencies to approve an Investigational New Drug (IND) application.
Key Activities:
In Vitro Studies: Laboratory tests conducted outside a living organism, often using cell cultures or isolated tissues, to determine a drug's mechanism of action and initial toxicity profile.
In Vivo Studies (Animal Models): Testing the drug in appropriate animal species to assess:
Toxicity: Identifying potential harmful effects and determining a safe starting dose for humans.
Pharmacology: Confirming the drug's therapeutic effect against the target disease model.
Pharmacokinetics (PK): Studying how the drug is absorbed, distributed, metabolized, and excreted by the body.
Pharmacodynamics (PD): Analyzing the drug's biochemical and physiological effects on the body.
The CRO provides the necessary infrastructure, specialized equipment, and scientific expertise to perform these complex, regulated studies.